1. Australia Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
CONNEQT Health Limited

CONNEQT Health Limited

CQT.AX
CONNEQT Health LimitedAU flagAustralian Securities Exchange
0.02
AUD
- -
- -
14.76MMarket Cap
CONNEQT Health Limited
CQT.AX
(Australian Securities Exchange)

Recent

price

0.02

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
FRC
0.95
0.78
0.52
0.41
0.51
0.28
0.28
0.22
0.17
0.12
0.06
0.05
0.03
0.03
0.03
0.05
Revenue per Share
-0.14
-0.1
-0.22
-0.13
0.15
-0.15
-0.07
-0.21
-0.17
-0.09
-0.04
-0.04
-0.06
-0.1
-0.13
-0.03
Basic EPS, GAAP
-0.07
-0.22
-0.14
-0.1
0.1
-0.08
-0.1
-0.21
-0.12
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.39
0.32
0.19
0.11
0.27
0.18
0.2
0.13
0.05
0.08
0.09
0.07
0.07
0.05
- -
0.01
Book Value per Share
0.38
0.31
0.19
0.11
0.27
0.18
0.2
0.13
0.05
0.08
0.09
0.07
0.07
0.05
-0.01
0.01
Tangible Book Value per Share
12
12
14
16
18
18
19
23
26
34
68
83
99
117
149
205
Basic Weighted Avg Shares
11
9
7
6
9
5
5
5
4
4
4
4
3
4
5
11
Sales/Revenue/Turnover
-25.65
-19.91
-35.84
-44.14
9.18
-63.34
-54.6
-109.5
-104.59
-75.92
-101.45
-101.54
-294.52
-317.81
-433.11
-66.08
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-2
-1
-3
-2
3
-3
-1
-5
-4
-3
-3
-3
-6
-12
-19
-7
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-15.09
-13.26
-41.31
-30.82
30.19
-52.71
-26.34
-95.75
-100.84
-73.92
-76.25
-77.35
-205.41
-290.38
-410.2
-62.04
Profit Margin (%)
4
3
3
1
5
3
4
3
1
4
-2
1
6
- -
-3
2
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
- -
1
- -
- -
LT Debt
5
4
3
2
5
3
4
3
1
5
7
6
8
7
-1
4
Total Equity
- -
- -
- -
- -
24.59
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
80.85
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
-31.89
-29.11
-91.04
-80.77
80.85
-65.26
-37.81
-128.59
-195.27
-99.96
-51.6
-51.76
-80.43
-162.65
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-51.08%
-150.96%
-646.16%
Free Cash Flow
411.32%
12.67%
47.51%
Net Income, GAAP
33.42%
37.43%
-64.18%
Sales/Revenue/Turnover
14.98%
34.69%
136.86%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
4
2023
- -
- -
- -
- -
5
2024
- -
- -
- -
- -
11

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
-0.1
2023
- -
- -
- -
- -
-0.13
2024
- -
- -
- -
- -
-0.03

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Similar Companies
Siemens Healthineers AG (SEMHF)
Mauna Kea Technologies S.A. (ALMKT.PA)
Techno Medica Co., Ltd. (6678.T)
Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS)
Stryker Corporation (0R2S.L)
Sensus Healthcare, Inc. (SRTS)
Business
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables, home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company was formerly known as CardieX Limited and changed its name to Conneqt Health Limited in September 2025. Conneqt Health Limited was founded in 1994 and is based in Sydney, Australia.